Nissay Asset Management Corp Pfizer Inc Transaction History

Nissay Asset Management Corp

$15.5 Billion
Q3 2024

A detailed history of Nissay Asset Management Corp transactions in Pfizer Inc stock. As of the latest transaction made, Nissay Asset Management Corp holds 749,940 shares of PFE stock, worth $19.6 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

749,940

Previous 737,858 1.64%

Holding current value

$19.6 Million

Previous $20.6 Million 5.12%

% of portfolio

0.14%

Previous 0.14%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $334,671 - $379,253	12,082 Added 1.64%	749,940 $21.7 Million
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $167,347 - $196,100	6,625 Added 0.91%	737,858 $20.6 Million
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $155,780 - $178,885	-6,017 Reduced 0.82%	731,233 $20.3 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $576,924 - $749,361	22,079 Added 3.09%	737,250 $21.2 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $193,245 - $225,885	6,022 Added 0.85%	715,171 $23.7 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $724,061 - $837,722	-20,046 Reduced 2.75%	709,149 $26 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $960,485 - $1.25 Million	-24,384 Reduced 3.24%	729,195 $29.8 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $3.13 Million - $4.08 Million	-74,926 Reduced 9.04%	753,579 $38.6 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $1.12 Million - $1.37 Million	25,590 Added 3.19%	828,505 $36.3 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $2.97 Million - $3.52 Million	63,855 Added 8.64%	802,915 $42.1 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $1.54 Million - $1.91 Million	33,718 Added 4.78%	739,060 $38.3 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $1.85 Million - $2.74 Million	-44,773 Reduced 5.97%	705,342 $41.7 Million
Q3 2021 Nov 10, 2021	BUY	$39.25 - $50.42 $2.71 Million - $3.48 Million	68,948 Added 10.12%	750,115 $32.3 Million
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $1.54 Million - $1.74 Million	-42,829 Reduced 5.92%	681,167 $26.7 Million
Q1 2021 May 11, 2021	BUY	$33.49 - $37.77 $224,249 - $252,907	6,696 Added 0.93%	723,996 $26.2 Million
Q4 2020 Feb 08, 2021	SELL	$33.47 - $42.56 $435,712 - $554,046	-13,018 Reduced 1.78%	717,300 $26.4 Million
Q3 2020 Oct 20, 2020	SELL	$31.75 - $37.25 $1.54 Million - $1.81 Million	-48,489 Reduced 6.23%	730,318 $26.8 Million
Q2 2020 Jul 27, 2020	BUY	$30.12 - $36.54 $3.42 Million - $4.15 Million	113,601 Added 17.08%	778,807 $25.5 Million
Q1 2020 May 05, 2020	SELL	$27.03 - $38.62 $534,085 - $763,092	-19,759 Reduced 2.88%	665,206 $21.7 Million
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $1.66 Million - $1.89 Million	-50,460 Reduced 6.86%	684,965 $26.8 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $2.37 Million - $3.07 Million	72,879 Added 11.0%	735,425 $26.4 Million
Q2 2019 Aug 07, 2019	SELL	$36.98 - $41.52 $2.64 Million - $2.96 Million	-71,318 Reduced 9.72%	662,546 $28.7 Million
Q1 2019 May 03, 2019	SELL	$37.5 - $41.2 $823,725 - $904,999	-21,966 Reduced 2.91%	733,864 $31.2 Million
Q4 2018 Feb 06, 2019	BUY	$38.47 - $43.86 $833,529 - $950,314	21,667 Added 2.95%	755,830 $33 Million
Q3 2018 Oct 30, 2018	BUY	$34.47 - $41.81 $1.08 Million - $1.31 Million	31,235 Added 4.44%	734,163 $32.4 Million
Q2 2018 Aug 08, 2018	SELL	$32.98 - $35.16 $2.82 Million - $3.01 Million	-85,585 Reduced 10.85%	702,928 $25.5 Million
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $506,794 - $587,951	-15,882 Reduced 1.97%	788,513 $28 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $26.8 Million - $28.4 Million	804,395	804,395 $29.1 Million

Others Institutions Holding PFE

# of Institutions

3,258

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nissay Asset Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Nissay Asset Management Corp with notifications on news.

Account

Nissay Asset Management Corp Pfizer Inc Transaction History